Sientra Announces FDA-Clearance of Novel Portfinder(TM) Technology

Stock Information for Sientra Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Sientra Inc.

Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
Sientra Reports Third Quarter Financial and Operational Results
Sientra to Present at the Stifel 2023 Healthcare Conference
Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook
Sientra Reports Record Second Quarter Financial and Operational Results
Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Sientra Announces Appointment of Alexander W. Casdin to Board of Directors

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.